[1]
L. Kessler, C. Falato, S. Margolin, J. Bergh, and T. Foukakis, “A retrospective safety and efficacy analysis of the first patients treated with eribulin for metastatic breast cancer in Stockholm, Sweden”, AO, vol. 54, no. 4, pp. 527–534, Apr. 2015.